Phase 1 Dose Escalation Study of Intra-Articular Administration of tgAAC94

Clinical trial NCT00617032 · COMPLETED

Trial details

NCT number: NCT00617032
Sponsor: Targeted Genetics Corporation
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2004-02-01
Primary completion: 2005-11-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.